CN1486178A - 组胺受体拮抗剂 - Google Patents

组胺受体拮抗剂 Download PDF

Info

Publication number
CN1486178A
CN1486178A CNA028036840A CN02803684A CN1486178A CN 1486178 A CN1486178 A CN 1486178A CN A028036840 A CNA028036840 A CN A028036840A CN 02803684 A CN02803684 A CN 02803684A CN 1486178 A CN1486178 A CN 1486178A
Authority
CN
China
Prior art keywords
histamine
receptor
antagonist
disease
selectivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028036840A
Other languages
English (en)
Chinese (zh)
Inventor
˹�ٷҡ�ղ��ɭ
斯蒂芬·詹金森
A
马克·A·奥赖利
A����ά
迈克尔·A·特里维西克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1486178A publication Critical patent/CN1486178A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA028036840A 2001-01-17 2002-01-10 组胺受体拮抗剂 Pending CN1486178A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0101223.6 2001-01-17
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
CN1486178A true CN1486178A (zh) 2004-03-31

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028036840A Pending CN1486178A (zh) 2001-01-17 2002-01-10 组胺受体拮抗剂

Country Status (31)

Country Link
EP (1) EP1353657A1 (es)
JP (1) JP2004517883A (es)
KR (1) KR20030069216A (es)
CN (1) CN1486178A (es)
AP (1) AP2002002401A0 (es)
AR (1) AR032101A1 (es)
BG (1) BG107834A (es)
BR (1) BR0206502A (es)
CA (1) CA2435121A1 (es)
CR (1) CR6983A (es)
CZ (1) CZ20031853A3 (es)
DO (1) DOP2002000325A (es)
EA (1) EA200300537A1 (es)
EC (1) ECSP034692A (es)
EE (1) EE200300335A (es)
GB (1) GB0101223D0 (es)
GT (1) GT200200003A (es)
HU (1) HUP0302767A2 (es)
IL (1) IL156087A0 (es)
IS (1) IS6818A (es)
MA (1) MA26980A1 (es)
MX (1) MXPA03006408A (es)
NO (1) NO20033223D0 (es)
OA (1) OA12440A (es)
PA (1) PA8537101A1 (es)
PL (1) PL362793A1 (es)
SK (1) SK8572003A3 (es)
SV (1) SV2003000849A (es)
TN (1) TNSN02003A1 (es)
WO (1) WO2002056871A2 (es)
ZA (1) ZA200304180B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
MXPA05002577A (es) * 2002-09-06 2005-09-20 Johnson & Johnson Uso de moduladores del receptor h4 de histamina para el tratamiento de alergia y asma.
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
HUE039713T2 (hu) 2012-06-08 2019-02-28 Sensorion H4 receptor inhibitorok tinnitus kezelésére

Also Published As

Publication number Publication date
NO20033223L (no) 2003-07-16
BR0206502A (pt) 2003-10-21
SV2003000849A (es) 2003-01-13
HUP0302767A2 (hu) 2003-11-28
CR6983A (es) 2003-11-25
GT200200003A (es) 2002-08-19
AR032101A1 (es) 2003-10-22
SK8572003A3 (en) 2004-07-07
MA26980A1 (fr) 2004-12-20
ZA200304180B (en) 2004-06-15
MXPA03006408A (es) 2003-10-15
PL362793A1 (en) 2004-11-02
OA12440A (en) 2006-05-22
EP1353657A1 (en) 2003-10-22
TNSN02003A1 (fr) 2005-12-23
WO2002056871A2 (en) 2002-07-25
IL156087A0 (en) 2003-12-23
NO20033223D0 (no) 2003-07-16
EA200300537A1 (ru) 2004-02-26
KR20030069216A (ko) 2003-08-25
IS6818A (is) 2003-05-15
BG107834A (bg) 2004-01-30
ECSP034692A (es) 2003-08-29
CA2435121A1 (en) 2002-07-25
AP2002002401A0 (en) 2002-03-31
PA8537101A1 (es) 2002-08-29
CZ20031853A3 (cs) 2004-07-14
EE200300335A (et) 2003-12-15
DOP2002000325A (es) 2003-01-31
GB0101223D0 (en) 2001-02-28
JP2004517883A (ja) 2004-06-17

Similar Documents

Publication Publication Date Title
US5543434A (en) Nasal administration of ketamine to manage pain
TWI221768B (en) Pharmaceutical composition comprising histamine H1 receptor antagonist and histamine H3 receptor antagonist providing nasal decongestant effect
MXPA96003633A (es) Uso de ketamina y dispositivo para la administracion nasal y ocular de ketamina para el manejo de dolor y para la detoxificacion
JP2004512260A (ja) 局所麻酔/オピオイド製剤およびその使用方法
CN102905689A (zh) 包含低剂量纳曲酮的液体鼻喷雾
JP2001517639A (ja) 鼻炎/結膜炎および感冒、感冒に似た症状および/または流行性感冒の症状を局所的に治療するための、鎮静作用を有しない抗ヒスタミンおよびα−アドレナリン作動薬を含む組合せ物の使用
BR112014000159A2 (pt) composição oral, e, uso de uma composição oral
TW200831078A (en) Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
AU2008259864B2 (en) Methods and compositions for administration of Oxybutynin
CN1486178A (zh) 组胺受体拮抗剂
US8703158B2 (en) Theobromine for the treatment of cough
US6008222A (en) Method for oral administration of buspirone and nefazodone
CN104684549A (zh) 治疗膀胱过度活动症的毒蕈碱性受体拮抗剂和β-3肾上腺素能受体激动剂的组合
EP2626065A1 (en) Compound composition for inhalation used for treating asthma
Hanson Cough mixtures-an overview
US20050089558A1 (en) Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
US20080207667A1 (en) Use of nalbuphine and related compounds to treat symptoms of respiratory problems
US7074834B2 (en) Long acting, reversible veterinary sedative and analgesic and method of use
JPH0517358A (ja) 睡眠誘起性無呼吸症治療剤
US20020132755A1 (en) Histamine receptor antagonists
CN101167709A (zh) 复方甲基麻黄碱胶囊及其制备方法
RU2023135622A (ru) Безопасное введение ингибитора mmp-12
WO2015054359A1 (en) Methods and compositions for symptomatic reflief of the common cold
IL308793A (en) Safe delivery of an MMP-12 inhibitor
JP2023553290A (ja) 慢性閉塞性肺疾患、喘息、肺炎、気管支炎、嚢胞性線維症、肺水腫、間質性肺疾患、サルコイドーシス、特発性肺胞線維症、急性呼吸窮迫症候群、および肺動脈性肺高血圧症を治療するための方法および組成物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1060300

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1060300

Country of ref document: HK